MedTrace Logo

Mask Ventilation Before and After Neuromuscular Blockade

NCT02237443 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2015-04-09

No results posted yet for this study

Summary

Anesthesia providers are taught to "test" that they can properly ventilate a patient's lungs before administering a neuromuscular blocking drug (NMBD), rendering the patient apneic. This is a traditional teaching, not based on empirical evidence. The investigators primary hypothesis is that ventilation after the administration of NMBDs is non-inferior with that before their administration with respect to the composite safety endpoint of inadequate (MVi) and dead-space only (Vds) ventilation.

Conditions

  • Anesthesia

Interventions

DRUG

Rocuronium

Administration of a NMBD

DRUG

Vecuronium Bromide

Administration of a NMBD

DRUG

Succinylcholine

Administration of a NMBD

Sponsors & Collaborators

Principal Investigators

  • Aaron M Joffe, DO · University of Washington Department of Anesthesiology and Pain Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2014-11-30
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02237443 on ClinicalTrials.gov